| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/02/2004 | US20040170630 Human monoclonal antibodies to heparanase |
| 09/02/2004 | US20040170629 Marker proteins for diagnosing smooth muscle cell abnormalities |
| 09/02/2004 | US20040170628 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 09/02/2004 | US20040170627 Antagonists of Myelin-associated Glycoprotein and their use in the treatment and/or prevention of Neurological diseases |
| 09/02/2004 | US20040170626 and inhibits IL-2 binding to CD25; can be produced by a hybridoma, a transfectoma or in a nonhuman transgenic animal; treating diseases including organ, tissue and cell transplant rejection, autoimmune diseases, inflammatory and hyperproliferative skin disorders, and lymphoid neoplasms |
| 09/02/2004 | US20040170624 active principle, especially the humanized monoclonal antibody JAQ1, that induces irreversible inactivation or degradation of the collagen receptor on thrombocytes; diagnostic agent for the determination of the expression rate of the collagen receptor GPVI |
| 09/02/2004 | US20040170623 having a concentration of at least 50 mg/ml of the antibody and containing an acidic component; nasal sprays and slow release formulations drying or freeze-drying |
| 09/02/2004 | US20040170621 inhibiting eosinophil chemotactic factor-L expression or activity by means including use of anti-ECF-L antibody, antisense S-oligonucleotide to ECF-L, mECF-L polyclonal antisera, rabbit preimmune antisera, OPG RANK-Fc or by inhibiting osteoclast formation; also administering mECF-L with RANKL |
| 09/02/2004 | US20040170620 Selected antibody compositions for binding to aminophospholipids |
| 09/02/2004 | DE10306331A1 Preparation of biocomplex-reaction pattern in vertebrate cells components, useful for diagnosis, treatment and prevention of e.g. viral infections, includes purification with specific antibodies |
| 09/02/2004 | CA2843744A1 Delta-endotoxin genes and methods for their use |
| 09/02/2004 | CA2787820A1 Glycoprotein antigen sima135 expressed in metastatic human tumor cells |
| 09/02/2004 | CA2516945A1 Therapeutic agent for spinal cord injury comprising interleukin-6 antagonist |
| 09/02/2004 | CA2516701A1 Modulation of the poliovirus receptor function |
| 09/02/2004 | CA2516454A1 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 09/02/2004 | CA2516371A1 Method of diagnosis of type 2 diabetes and early onset thereof |
| 09/02/2004 | CA2516366A1 Glycorpotein antigen sima135 expressed in metastatic human tumor cells |
| 09/02/2004 | CA2516335A1 A method of diagnosis and treatment |
| 09/02/2004 | CA2516286A1 Expression in plants of antibodies against enterotoxigenic escherichia coli |
| 09/02/2004 | CA2516191A1 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 09/02/2004 | CA2516087A1 Antibodies against respiratory ailment-causing pathogens |
| 09/02/2004 | CA2515779A1 Contraceptive method and compositions related to proteasomal interference |
| 09/02/2004 | CA2515398A1 Idiotypic vaccine |
| 09/02/2004 | CA2514979A1 Antibody vaccine conjugates and uses therefor |
| 09/02/2004 | CA2498650A1 Mycobacterial diagnostics |
| 09/01/2004 | EP1452600A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/01/2004 | EP1452588A1 Reductase gene and use of the same |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452541A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 09/01/2004 | EP1452093A1 Chimeric nonhuman animal |
| 09/01/2004 | EP1451578A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 09/01/2004 | EP1451552A2 Reagents and methods useful for detecting diseases of the breast |
| 09/01/2004 | EP1451368A2 Single nucleotide polymorphisms in gh-1 |
| 09/01/2004 | EP1451343A2 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof |
| 09/01/2004 | EP1451338A1 Recombinant antibodies for the detection and neutralization of anthrax toxin |
| 09/01/2004 | EP1451337A2 Nogo receptor-mediated blockade of axonal growth |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451312A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/01/2004 | EP1451307A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/01/2004 | EP1451293A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 09/01/2004 | EP1451226A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |
| 09/01/2004 | EP1451223A2 Expression control using variable intergenic sequences |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451221A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 09/01/2004 | EP1451220A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 09/01/2004 | EP1451219A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 09/01/2004 | EP1451216A1 Immunointeractive molecules and uses thereof |
| 09/01/2004 | EP1451213A2 Human and murine cytokine polypeptides |
| 09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
| 09/01/2004 | EP1451193A1 Podophyllotoxins as antiproliferative agents |
| 09/01/2004 | EP1451109A2 Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
| 09/01/2004 | EP1450857A2 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/01/2004 | EP1450845A2 15603, a human ion channel family member |
| 09/01/2004 | EP1450828A2 In situ immunization |
| 09/01/2004 | EP1450752A2 Multivalent streptococcal vaccine compositions and methods for use |
| 09/01/2004 | EP1303534A4 Promyostatin peptides and methods of using same |
| 09/01/2004 | EP1042482B1 Acetyl-coa-carboxylase from candida albicans |
| 09/01/2004 | EP0969867B1 Use of anti-il-12 antibodies in transplantation rejection |
| 09/01/2004 | EP0941369B1 Dna for evaluating the progression potential of cervical lesions |
| 09/01/2004 | EP0937139B1 Amidase |
| 09/01/2004 | EP0767914B1 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 09/01/2004 | EP0753011B1 Thymidine kinase tk1, peptide, corresponding antibodies and use of these in determination of tumor proliferation |
| 09/01/2004 | EP0634936B1 Methods for immunocontraception |
| 09/01/2004 | EP0616640B1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 09/01/2004 | CN1526072A Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
| 09/01/2004 | CN1526017A Gene associated with leishmania parasite virulence |
| 09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
| 09/01/2004 | CN1525981A T1R taste receptors and genes encoding same |
| 09/01/2004 | CN1525869A Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 09/01/2004 | CN1525168A Methods of detecting alzheimer's disease |
| 09/01/2004 | CN1524950A Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof |
| 09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
| 09/01/2004 | CN1164947C Process for preparing cross-linking antibody using solid-phase immunoadsorption method |
| 09/01/2004 | CN1164616C Recombinant hepatitis B virus immune globulin |
| 09/01/2004 | CN1164614C Memory clearing protein and its application |
| 09/01/2004 | CN1164332C Preparation method of horse SARS-resisting serum |
| 08/31/2004 | US6784163 Inhibition of cationic amino acid transporter protein and uses thereof |
| 08/31/2004 | US6783986 Sucrose phosphate synthetase (SPS), a preparation method and cDNA therefor, and use of the cDNA for modifying SPS expression in plant cells |
| 08/31/2004 | US6783960 Polypeptide for use in the treatment of thrombosis and sepsis |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/31/2004 | US6783759 Compositions and methods for modulating variola virus |
| 08/31/2004 | US6783758 Diagnosis and treatment of malignant neoplasms |
| 08/31/2004 | CA2194369C Methods and compositions for the specific coagulation of vasculature |
| 08/26/2004 | WO2004073319A2 Methods and compounds for raising antibodies and for screening antibody repertoires |
| 08/26/2004 | WO2004072287A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 08/26/2004 | WO2004072286A1 Substance specific to human pd-1 |
| 08/26/2004 | WO2004072266A2 Antibody affinity engineering by serial epitope-guided complementarity replacement |
| 08/26/2004 | WO2004072265A2 Methods for monitoring drug activities in vivo |
| 08/26/2004 | WO2004072263A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | WO2004072262A2 Cultured cd14+ antigen presenting cells |
| 08/26/2004 | WO2004072241A2 Compositions and methods for cleaving iap |
| 08/26/2004 | WO2004072117A2 Antibodies to c-met for the treatment of cancers |
| 08/26/2004 | WO2004072116A2 ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-1β |
| 08/26/2004 | WO2004072115A2 Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies |
| 08/26/2004 | WO2004072114A1 Method of diagnosing bovince blood coagulation factor xi deficiency |
| 08/26/2004 | WO2004071530A2 Identification of cellular polypeptides differentially expressed by tumor cells |